1Varkarakis J,Bartsch G,Horninger W. Long-term morbidity and mortality of transurethral prostatectomy:a 1O-year follow-up[J].Prostate,2004,(03):248.
2Tubaro A,Carter S,Hind A. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia[J].The Journal of Urology,2001,(04):172-176.
7Pasin E, Josephson DY, Mitra AP, et al. Superficial bladder canceran update on etiology, molecular development, classifi-ation, and natural history [ J ]. Rev Urol,2008,10 ( 1 ) :31-43.
8Dalbagni G. The management of superficial bladder cancer [ J ]. NatClin Pract Urol,2007,4 (5) :254-260.
9Yaman Ls, Yurdakul T, Zissis WP, et al. Intravesical rnitoxantrone for superficial bladder tumors [J ]. Anti-cancer Drugs, 1994,5:97.
10Volpe A, Racioppi M, Sacco E; et al. New therapeutical approaches for non muscle invasive bladder cancer[ J]. Arch Ital Urol Androl,2008,12 (4) : 136-142.
